DORLING JANET (Chief Commercial Officer) sold 6K shares of CYMABAY THERAPEUTICS, INC. on the open market
Open‑market sale worth $191.8K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/14/2024ACC: 0001062993-24-003202
Officer· Chief Commercial Officer
Since Aug 2019
-6K
Net shares
Net seller
$191.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6K acquired · 12K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6K
Price / share
$4.63
Trade value
$27.78K
% of position
New position
2/12/2024
0.00→6K
Common Stock
Direct
Shares
−6K
Price / share
$31.97
Trade value
$191.85K
% of position
New position
2/12/2024
6K→0.00
Total
Net shares
+0.00
Net value
-$164.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2024 | M · Option Exercise | +6K | $4.63 | $27.78K | New position | 0.00 | 6K |
| Common Stock Direct | 2/12/2024 | S · Sale | −6K | $31.97 | $191.85K | New position | 6K | 0.00 |
| Total | +0.00 | -$164.07K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
6K shares
Shares
−6K
Strike price
4.63
Held after
55K
Exercisable
—
2/12/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock6K shares | 2/12/2024 | M · Option Exercise | −6K | 4.63 | — | 55K |